Core Laboratories N.V.
CLB · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $19 | $15 | $15 | $18 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $127 | $123 | $115 | $107 |
| Inventory | $59 | $72 | $60 | $45 |
| Other Curr. Assets | $21 | $13 | $21 | $19 |
| Total Curr. Assets | $227 | $223 | $212 | $189 |
| Property Plant & Equip (Net) | $154 | $153 | $157 | $172 |
| Goodwill | $99 | $99 | $99 | $99 |
| Intangibles | $6 | $7 | $7 | $8 |
| Long-Term Investments | $5 | $5 | $4 | $4 |
| Tax Assets | $70 | $0 | $69 | $70 |
| Other NC Assets | $30 | $99 | $29 | $37 |
| Total NC Assets | $364 | $363 | $367 | $392 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $590 | $586 | $578 | $581 |
| Liabilities | – | – | – | – |
| Payables | $35 | $34 | $46 | $30 |
| Short-Term Debt | $11 | $10 | $12 | $12 |
| Tax Payable | $12 | $7 | $8 | $12 |
| Deferred Revenue | $9 | $5 | $6 | $8 |
| Other Curr. Liab. | $31 | $32 | $32 | $29 |
| Total Curr. Liab. | $98 | $88 | $103 | $91 |
| LT Debt | $169 | $205 | $211 | $238 |
| Deferred Rev, NC | $0 | $31 | $32 | $39 |
| Deferred Tax Liab, NC | $14 | $13 | $23 | $24 |
| Other NC Liab. | $52 | $20 | $21 | $28 |
| Total NC Liab. | $235 | $268 | $286 | $329 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $54 | $52 | $50 | $62 |
| Total Liabilities | $333 | $357 | $389 | $420 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $1 | $1 |
| Retained Earnings | $150 | $121 | $86 | $68 |
| AOCI | -$6 | -$5 | -$4 | -$10 |
| Other Equity | $107 | $109 | $101 | $97 |
| Total Equity | $252 | $225 | $184 | $156 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $6 | $5 | $5 | $5 |
| Total Liab. & Tot. Equity | $590 | $586 | $578 | $581 |
| Net Debt | $161 | $200 | $207 | $233 |